Off Patent
December 2027

Toviaz

fesoterodine fumarate

Pfizer Inc

Tablet, extended release (oral) · NDA 022030

Last listed protection ends
December 7, 2027

The FDA lists 3 patents for Toviaz, and this is the day the last one ends. It is not the date a generic goes on sale.

Patents and exclusivities

  1. Patent 7,807,715
    Claims the drug product and a use (U-913)
  2. Patent 8,088,398
    Claims the drug product and a use (U-913)
  3. Patent 8,501,723
    Claims the drug product
  4. Patent 7,807,715
    Pediatric extension: six more months
  5. Patent 8,088,398
    Pediatric extension: six more months
  6. Patent 8,501,723
    Pediatric extension: six more months